{"content":"<li class=\"n-box-item date-title\" data-end=\"1350359999\" data-start=\"1350273600\" data-txt=\"Wednesday, December 18, 2019\">Monday, October 15, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"586901\" data-ts=\"1350342172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AONEQ\" target=\"_blank\">AONEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A123 Systems (AONE) says that it may not have sufficient cash to fund operations and may need to...</a></h4><p>A123 Systems (AONE) says that it may not have sufficient cash to fund operations and may need to seek <a target=\"_blank\" href=\"http://www.streetinsider.com/Trading+Halts/A123+Systems+%28AONE%29+Gets+Event+of+Default+Waived+on+%2475M+Loan+Interest+Payment/7793808.html\">bankruptcy protection</a>. The company failed to meet interest payments on approximately $143M of its material debt agreements today, and as a result, expects to be in default by tomorrow. Shares <font color=\"red\">-47%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"586901\" data-linked=\"A123 Systems (AONE) says that it may not have sufficient cash to fund operations and may need to...\" data-tweet=\"$AONEQ - A123 Systems (AONE) says that it may not have sufficient cash to fund operations and may need to seek bankruptcy protection. The company failed to meet interest payments on approximately $143M of its material debt agreements today, and as a res... https://seekingalpha.com/news/586901?source=tweet\" data-url=\"https://seekingalpha.com/news/586901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586891\" data-ts=\"1350339739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBDC\" target=\"_blank\">GBDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Golub Capital BDC (NASDAQ:GBDC) slips after announcing a 2.6M share secondary offering . Wells...</a></h4><p>Golub Capital BDC (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GBDC\" title=\"Golub Capital BDC\">GBDC</a>) slips after announcing a 2.6M share secondary offering . Wells Fargo and UBS are acting as joint book-running managers for the offering, and the company intends to use the net proceeds to invest in portfolio companies in accordance with its investment objective and strategies, as well as for general corporate purposes. Shares <font color=\"red\">-2.6%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"586891\" data-linked=\"Golub Capital BDC (NASDAQ:GBDC) slips after announcing a 2.6M share secondary offering . Wells...\" data-tweet=\"$GBDC - Golub Capital BDC (NASDAQ:GBDC) slips after announcing a 2.6M share secondary offering . Wells Fargo and UBS are acting as joint book-running managers for the offering, and the company intends to use the net proceeds to invest in portfolio compa... https://seekingalpha.com/news/586891?source=tweet\" data-url=\"https://seekingalpha.com/news/586891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586881\" data-ts=\"1350338698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOEZ\" target=\"_blank\">JOEZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Joe&#39;s Jeans (NASDAQ:JOEZ): Q3 beats across the board on a 25% jump in total revenue, due...</a></h4><p>More on Joe's Jeans (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JOEZ\" title=\"Joe's Jeans Inc.\">JOEZ</a>): <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/586671\">Q3 beats</a> across the board on a 25% jump in total revenue, due in large part to writedowns during the same prior year period. Net sales from retail +24% Y/Y, same store sales +7%, with contribution from 25 stores compared to 21 stores ove the prior year period. Gross margins increased to 71% from 67%. Shares <font color=\"green\">+6.9%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"586881\" data-linked=\"More on Joe&#39;s Jeans (NASDAQ:JOEZ): Q3 beats across the board on a 25% jump in total revenue, due...\" data-tweet=\"$JOEZ - More on Joe&#39;s Jeans (NASDAQ:JOEZ): Q3 beats across the board on a 25% jump in total revenue, due in large part to writedowns during the same prior year period. Net sales from retail +24% Y/Y, same store sales +7%, with contribution from 25 store... https://seekingalpha.com/news/586881?source=tweet\" data-url=\"https://seekingalpha.com/news/586881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586841\" data-ts=\"1350336678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRO\" target=\"_blank\">BRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brown &amp;amp; Brown (NYSE:BRO): Q3 EPS of $0.34 misses by $0.01. Revenue of $303.8M (+16.7% Y/Y)...</a></h4><b>Brown &amp; Brown (NYSE:<a href=\"https://seekingalpha.com/symbol/BRO\" title=\"Brown &amp; Brown Insurance\">BRO</a>):</b> Q3 EPS of $0.34 <font color=\"red\">misses by $0.01</font>. Revenue of $303.8M (+16.7% Y/Y) <font color=\"red\">misses by $8M</font>. Shares <font color=\"red\">-3.8%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"586841\" data-linked=\"Brown &amp;amp; Brown (NYSE:BRO): Q3 EPS of $0.34 misses by $0.01. Revenue of $303.8M (+16.7% Y/Y)...\" data-tweet=\"$BRO - Brown &amp; Brown (NYSE:BRO): Q3 EPS of $0.34 misses by $0.01. Revenue of $303.8M (+16.7% Y/Y) misses by $8M. Shares -3.8% AH. (PR) https://seekingalpha.com/news/586841?source=tweet\" data-url=\"https://seekingalpha.com/news/586841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586831\" data-ts=\"1350336147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCEP\" target=\"_blank\">MCEP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mid-Con Energy (NASDAQ:MCEP) announces a 4M unit offering , consisting of 1M common units...</a></h4><p>Mid-Con Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MCEP\" title=\"Mid-Con Energy Partners\">MCEP</a>) announces a <a target=\"_blank\" href=\"http://www.marketwatch.com/story/mid-con-energy-partners-lp-announces-public-offering-of-common-units-2012-10-15\">4M unit offering</a> , consisting of 1M common units representing limited partner interests, plus an additional 3M units for Yorktown Energy Partners VI, Yorktown Energy Partners VII, and Yorktown Energy Partners VIII. RBC Capital Markets, Raymond James, UBS and Wells Fargo Securities are acting as joint book-running managers, with Baird, Oppenheimer and Stephens as co-managers for the offering. Shares <font color=\"red\">-2.2%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"586831\" data-linked=\"Mid-Con Energy (NASDAQ:MCEP) announces a 4M unit offering , consisting of 1M common units...\" data-tweet=\"$MCEP - Mid-Con Energy (NASDAQ:MCEP) announces a 4M unit offering , consisting of 1M common units representing limited partner interests, plus an additional 3M units for Yorktown Energy Partners VI, Yorktown Energy Partners VII, and Yorktown Energy Part... https://seekingalpha.com/news/586831?source=tweet\" data-url=\"https://seekingalpha.com/news/586831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586821\" data-ts=\"1350335818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586821\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microchip (NASDAQ:MCHP) -3% AH after warning it expects to report FQ2 (Sep. quarter) revenue of...</a></h4><p>Microchip (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MCHP\" title=\"Microchip Technology Incorporated\">MCHP</a>) <font color=\"red\">-3%</font> AH after <a target=\"_blank\" href=\"http://finance.yahoo.com/news/microchip-technology-announces-preliminary-net-203000450.html\">warning</a> it expects to report FQ2 (Sep. quarter) revenue of $407M-$408M, below a consensus of $420.3M. The microcontroller vendor, often seen as <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/85984\">a bellwether</a> for broader chip industry demand, blames \"macroeconomic and industry conditions\" in general. \"The overall global economic outlook continues to be poor and is adversely impacting our business as well as the rest of the semiconductor industry.\" (also: <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/575051\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/567701\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"586821\" data-linked=\"Microchip (NASDAQ:MCHP) -3% AH after warning it expects to report FQ2 (Sep. quarter) revenue of...\" data-tweet=\"$MCHP $SOXX $SMH - Microchip (NASDAQ:MCHP) -3% AH after warning it expects to report FQ2 (Sep. quarter) revenue of $407M-$408M, below a consensus of $420.3M. The microcontroller vendor, often seen as a bellwether for broader chip industry demand, blames... https://seekingalpha.com/news/586821?source=tweet\" data-url=\"https://seekingalpha.com/news/586821\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586811\" data-ts=\"1350335297\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHCP\" target=\"_blank\">DHCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586811\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walter Investment Corp. (WAC) -8.8% AH following its announcement of a secondary offering of...</a></h4><p>Walter Investment Corp. (WAC) <font color=\"red\">-8.8%</font> AH following its announcement of a secondary offering of 4.5M shares along with $265m in convertible senior notes. The company intends to use about $95M of the proceeds to complete <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/520281\">its acquisition</a> of Reverse Mortgage Solutions. The rest of the money will create a war chest for future acquisitions in the servicing sector. (PR)</p><div class=\"tiny-share-widget\" data-id=\"586811\" data-linked=\"Walter Investment Corp. (WAC) -8.8% AH following its announcement of a secondary offering of...\" data-tweet=\"$DHCP - Walter Investment Corp. (WAC) -8.8% AH following its announcement of a secondary offering of 4.5M shares along with $265m in convertible senior notes. The company intends to use about $95M of the proceeds to complete its acquisition of Reverse M... https://seekingalpha.com/news/586811?source=tweet\" data-url=\"https://seekingalpha.com/news/586811\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586751\" data-ts=\"1350333852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RATE\" target=\"_blank\">RATE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bankrate (NYSE:RATE) -23% AH after announcing preliminary Q3 results with revenue expected at...</a></h4><p>Bankrate (NYSE:<a href=\"https://seekingalpha.com/symbol/RATE\" title=\"Bankrate Inc.\">RATE</a>) <font color=\"red\">-23%</font> AH after announcing preliminary Q3 results with revenue expected at $115.5M-$117.5M vs. consensus of $132.7M, and earnings of $0.11-$0.13 vs. consensus of $0.20. The results don't seem to square with what other reports say is very strong mortgage refinance activity. (PR)</p><div class=\"tiny-share-widget\" data-id=\"586751\" data-linked=\"Bankrate (NYSE:RATE) -23% AH after announcing preliminary Q3 results with revenue expected at...\" data-tweet=\"$RATE - Bankrate (NYSE:RATE) -23% AH after announcing preliminary Q3 results with revenue expected at $115.5M-$117.5M vs. consensus of $132.7M, and earnings of $0.11-$0.13 vs. consensus of $0.20. The results don&#39;t seem to square with what other reports ... https://seekingalpha.com/news/586751?source=tweet\" data-url=\"https://seekingalpha.com/news/586751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586721\" data-ts=\"1350332754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDFC\" target=\"_blank\">WDFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586721\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on WD-40 (NASDAQ:WDFC): FQ4 misses consensus estimates across the board. The company blames...</a></h4><p>More on WD-40 (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WDFC\" title=\"WD-40 Company\">WDFC</a>): <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/586661\">FQ4 misses</a> consensus estimates across the board. The company blames the miss on lower sales in its harvest brand home care and cleaning products unit, plus higher input costs and adverse currency fluctuation. It also cuts its outlook for FY13, now expecting net sales of $356M to $370M, or $2.31 to $2.40 per share, versus Street expectations of $2.56 per share. Shares <font color=\"red\">-8%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"586721\" data-linked=\"More on WD-40 (NASDAQ:WDFC): FQ4 misses consensus estimates across the board. The company blames...\" data-tweet=\"$WDFC - More on WD-40 (NASDAQ:WDFC): FQ4 misses consensus estimates across the board. The company blames the miss on lower sales in its harvest brand home care and cleaning products unit, plus higher input costs and adverse currency fluctuation. It also... https://seekingalpha.com/news/586721?source=tweet\" data-url=\"https://seekingalpha.com/news/586721\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586681\" data-ts=\"1350332109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRS\" target=\"_blank\">HRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of military contractor Harris Corp. (HRS -4%) slumped today after Lazard cut the stock to...</a></h4>Shares of military contractor Harris Corp. (<a href='https://seekingalpha.com/symbol/HRS' title='Harris Corporation'>HRS</a> <font color=\"red\">-4%</font>) slumped today after Lazard <a target=\"_blank\" href=\"http://cut the stock\">cut the stock</a> to Sell, citing a slowdown in orders and no material near-term catalysts to maintain or accelerate current share performance.<div class=\"tiny-share-widget\" data-id=\"586681\" data-linked=\"Shares of military contractor Harris Corp. (HRS -4%) slumped today after Lazard cut the stock to...\" data-tweet=\"$HRS $LHX - Shares of military contractor Harris Corp. (HRS -4%) slumped today after Lazard cut the stock to Sell, citing a slowdown in orders and no material near-term catalysts to maintain or accelerate current share performance. https://seekingalpha.com/news/586681?source=tweet\" data-url=\"https://seekingalpha.com/news/586681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586671\" data-ts=\"1350331628\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOEZ\" target=\"_blank\">JOEZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Joe&#39;s Jeans (NASDAQ:JOEZ): Q3 EPS of $0.02 beats by $0.03. Revenue of $30.3M (+25% Y/Y) beats by...</a></h4><b>Joe's Jeans (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JOEZ\" title=\"Joe's Jeans Inc.\">JOEZ</a>):</b> Q3 EPS of $0.02 <font color=\"green\">beats by $0.03</font>. Revenue of $30.3M (+25% Y/Y) <font color=\"green\">beats by $3M</font>. Shares <font color=\"green\">+7.8%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"586671\" data-linked=\"Joe&#39;s Jeans (NASDAQ:JOEZ): Q3 EPS of $0.02 beats by $0.03. Revenue of $30.3M (+25% Y/Y) beats by...\" data-tweet=\"$JOEZ - Joe&#39;s Jeans (NASDAQ:JOEZ): Q3 EPS of $0.02 beats by $0.03. Revenue of $30.3M (+25% Y/Y) beats by $3M. Shares +7.8% AH. (PR) https://seekingalpha.com/news/586671?source=tweet\" data-url=\"https://seekingalpha.com/news/586671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586661\" data-ts=\"1350331486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDFC\" target=\"_blank\">WDFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WD-40 Company (NASDAQ:WDFC): FQ4 EPS of $0.56 misses by $0.14. Revenue of $84.9M (-6% Y/Y)...</a></h4><b>WD-40 Company (NASDAQ:<a href=\"https://seekingalpha.com/symbol/WDFC\" title=\"WD-40 Company\">WDFC</a>):</b> FQ4 EPS of $0.56 <font color=\"red\">misses by $0.14</font>. Revenue of $84.9M (-6% Y/Y) <font color=\"red\">misses by $9M</font>. Shares <font color=\"red\">-6.6%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"586661\" data-linked=\"WD-40 Company (NASDAQ:WDFC): FQ4 EPS of $0.56 misses by $0.14. Revenue of $84.9M (-6% Y/Y)...\" data-tweet=\"$WDFC - WD-40 Company (NASDAQ:WDFC): FQ4 EPS of $0.56 misses by $0.14. Revenue of $84.9M (-6% Y/Y) misses by $9M. Shares -6.6% AH. (PR) https://seekingalpha.com/news/586661?source=tweet\" data-url=\"https://seekingalpha.com/news/586661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586641\" data-ts=\"1350331403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICUI\" target=\"_blank\">ICUI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ICU Medical (NASDAQ:ICUI): Q3 EPS of $0.82 beats by $0.14. Revenue of $81.4M (+6.5% Y/Y)...</a></h4><b>ICU Medical (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ICUI\" title=\"ICU Medical, Inc.\">ICUI</a>):</b> Q3 EPS of $0.82 <font color=\"green\">beats by $0.14</font>. Revenue of $81.4M (+6.5% Y/Y) in-line. Shares <font color=\"red\">-6.5%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"586641\" data-linked=\"ICU Medical (NASDAQ:ICUI): Q3 EPS of $0.82 beats by $0.14. Revenue of $81.4M (+6.5% Y/Y)...\" data-tweet=\"$ICUI - ICU Medical (NASDAQ:ICUI): Q3 EPS of $0.82 beats by $0.14. Revenue of $81.4M (+6.5% Y/Y) in-line. Shares -6.5% AH. (PR) https://seekingalpha.com/news/586641?source=tweet\" data-url=\"https://seekingalpha.com/news/586641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586571\" data-ts=\"1350330515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPGI\" target=\"_blank\">CPGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese paper-packaging maker China Shengda Packaging Group (CPGI +26.4%) jumps after saying...</a></h4><p>Chinese paper-packaging maker China Shengda Packaging Group (<a href=\"https://seekingalpha.com/symbol/CPGI\" title=\"China Shengda Packaging Group, Inc.\">CPGI</a> <font color=\"green\">+26.4%</font>) jumps after saying it's received an offer from Chairman Nengbin Fang to take the company private in a cash deal at $1.40 per share, valuing it at roughly $54.3M. Mr. Fang and his family currently own about 54% of the outstanding stock.</p><div class=\"tiny-share-widget\" data-id=\"586571\" data-linked=\"Chinese paper-packaging maker China Shengda Packaging Group (CPGI +26.4%) jumps after saying...\" data-tweet=\"$CPGI - Chinese paper-packaging maker China Shengda Packaging Group (CPGI +26.4%) jumps after saying it&#39;s received an offer from Chairman Nengbin Fang to take the company private in a cash deal at $1.40 per share, valuing it at roughly $54.3M. Mr. Fang ... https://seekingalpha.com/news/586571?source=tweet\" data-url=\"https://seekingalpha.com/news/586571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586551\" data-ts=\"1350328573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem (CUR +7.3%) pops after releasing positive results for its NSI-566 study, a spinal...</a></h4><p>Neuralstem (<a href=\"https://seekingalpha.com/symbol/CUR\" title=\"Neuralstem, Inc.\">CUR</a> <font color=\"green\">+7.3%</font>) pops after releasing positive results for its NSI-566 study, a spinal cord-derived neural stem cell line tested in a rat model of ischemic stroke. The data showed significant improvement in both motor and neurological tests, with the rats treated with the highest dose showing the most significant improvement in both categories.</p><div class=\"tiny-share-widget\" data-id=\"586551\" data-linked=\"Neuralstem (CUR +7.3%) pops after releasing positive results for its NSI-566 study, a spinal...\" data-tweet=\"$CUR $SNCA - Neuralstem (CUR +7.3%) pops after releasing positive results for its NSI-566 study, a spinal cord-derived neural stem cell line tested in a rat model of ischemic stroke. The data showed significant improvement in both motor and neurological... https://seekingalpha.com/news/586551?source=tweet\" data-url=\"https://seekingalpha.com/news/586551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586521\" data-ts=\"1350328089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586521\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SanDisk (SNDK +3.1%) is rallying courtesy of an upgrade to Outperform from Wedbush: the firm...</a></h4>SanDisk (SNDK <font color='green'>+3.1%</font>) is rallying courtesy of an <a target=\"_blank\" href=\"http://www.thestreet.com/story/11736588/1/analysts-actions-atk-cost-isrg-low.html?cm_ven=GOOGLEN\">upgrade to Outperform</a> from Wedbush: the firm cites a favorable NAND flash memory supply/demand balance (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/575661\">Goldman </a>feels likewise) and strong OEM design wins (the iPhone 5 is among them).<div class=\"tiny-share-widget\" data-id=\"586521\" data-linked=\"SanDisk (SNDK +3.1%) is rallying courtesy of an upgrade to Outperform from Wedbush: the firm...\" data-tweet=\"$WDC - SanDisk (SNDK +3.1%) is rallying courtesy of an upgrade to Outperform from Wedbush: the firm cites a favorable NAND flash memory supply/demand balance (Goldman feels likewise) and strong OEM design wins (the iPhone 5 is among them). https://seekingalpha.com/news/586521?source=tweet\" data-url=\"https://seekingalpha.com/news/586521\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586491\" data-ts=\"1350326927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRO\" target=\"_blank\">MRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon Oil (MRO +1.5%) moves higher following a Reuters report it is looking to sell ~100K...</a></h4><p>Marathon Oil (<a href=\"https://seekingalpha.com/symbol/MRO\" title=\"Marathon Oil Corporation\">MRO</a> <font color=\"green\">+1.5%</font>) moves higher following a Reuters report it is <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/10/15/marathonoil-eagleford-idUSL1E8LFDD720121015\">looking to sell</a> ~100K acres of undeveloped oil and gas properties in the Eagle Ford basin in south Texas. MRO owns ~325K total acres in the area.</p><div class=\"tiny-share-widget\" data-id=\"586491\" data-linked=\"Marathon Oil (MRO +1.5%) moves higher following a Reuters report it is looking to sell ~100K...\" data-tweet=\"$MRO - Marathon Oil (MRO +1.5%) moves higher following a Reuters report it is looking to sell ~100K acres of undeveloped oil and gas properties in the Eagle Ford basin in south Texas. MRO owns ~325K total acres in the area. https://seekingalpha.com/news/586491?source=tweet\" data-url=\"https://seekingalpha.com/news/586491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586461\" data-ts=\"1350326341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISRG\" target=\"_blank\">ISRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuitive Surgical (ISRG +3.1%) trades higher ahead of tomorrow&#39;s Q3 report and an upgrade to...</a></h4><p>Intuitive Surgical (<a href=\"https://seekingalpha.com/symbol/ISRG\" title=\"Intuitive Surgical, Inc.\">ISRG</a> <font color=\"green\">+3.1%</font>) trades higher ahead of tomorrow's Q3 report and an <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/JPMorgan+Upgrades+Intuitive+Surgical+%28ISRG%29+to+Overweight/7791061.html\">upgrade to Outperform</a> by JPMorgan earlier today. The firm says that despite declines in domestic prostate-cancer surgeries there's compelling risk/reward in the shares, with meaningful opportunities emerging in other cancers and additional areas which, collectively, should more than offset the prostate-cancer softness and drive up Street estimates for the next several years.</p><div class=\"tiny-share-widget\" data-id=\"586461\" data-linked=\"Intuitive Surgical (ISRG +3.1%) trades higher ahead of tomorrow&#39;s Q3 report and an upgrade to...\" data-tweet=\"$ISRG - Intuitive Surgical (ISRG +3.1%) trades higher ahead of tomorrow&#39;s Q3 report and an upgrade to Outperform by JPMorgan earlier today. The firm says that despite declines in domestic prostate-cancer surgeries there&#39;s compelling risk/reward in the s... https://seekingalpha.com/news/586461?source=tweet\" data-url=\"https://seekingalpha.com/news/586461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586421\" data-ts=\"1350324650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWI\" target=\"_blank\">TWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan International (TWI +5.3%) shares are sharply higher after Jefferies raises its rating to...</a></h4><p>Titan International (<a href=\"https://seekingalpha.com/symbol/TWI\" title=\"Titan International Inc.\">TWI</a> <font color=\"green\">+5.3%</font>) shares are sharply higher after Jefferies <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Jefferies+Upgrades+Titan+International+%28TWI%29+to+Buy%2C+Favorable+RiskReward/7791194.html\">raises its rating</a> to Buy from Hold, seeing a favorable risk/reward profile following a recent pullback. The firm views a potential guidance update and more discussion of its Europe acquisition as potential catalysts for TWI; otherwise, it sees <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/Jefferies+Says+Prep+for+Downside+in+Machinery+Stocks%2C+Keep+Powder+Dry+/7791661.html\"> earnings and forecast risk</a> in machinery stocks <a href=\"https://seekingalpha.com/symbol/CAT\" title=\"Caterpillar Inc.\">CAT</a>, <a href=\"https://seekingalpha.com/symbol/ETN\" title=\"Eaton Corp. plc\">ETN</a> and <a href=\"https://seekingalpha.com/symbol/KMT\" title=\"Kennametal Inc.\">KMT</a>.</p><div class=\"tiny-share-widget\" data-id=\"586421\" data-linked=\"Titan International (TWI +5.3%) shares are sharply higher after Jefferies raises its rating to...\" data-tweet=\"$TWI $TWI $CAT - Titan International (TWI +5.3%) shares are sharply higher after Jefferies raises its rating to Buy from Hold, seeing a favorable risk/reward profile following a recent pullback. The firm views a potential guidance update and more discus... https://seekingalpha.com/news/586421?source=tweet\" data-url=\"https://seekingalpha.com/news/586421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586351\" data-ts=\"1350323416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586351\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead (GILD -0.9%) slips a bit today after Bristol-Myers (BMY +3.2%) and Abbott (ABT +3.7%)...</a></h4>Gilead (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-0.9%</font>) slips a bit today after Bristol-Myers (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"green\">+3.2%</font>) and Abbott (<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color=\"green\">+3.7%</font>) both reported favorable study results for their HCV drugs (<a target=\"_blank\" target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/586141\">I</a>,<a target=\"_blank\" target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/586281\">II</a>). Deutsche Bank <a target=\"_blank\" target=\"_blank\" href=\"http://ransquawk.com/headlines/gilead-gild-outlook-unchanged-following-competitor-hcv-data-according-to-deutsche-bank-15-10-2012\">defends the stock</a> , saying the results of these studies show that utilizing different drug combinations yields more effective HCV treatments, and that this data actually bodes well for <a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>'s 7977-based class combos, for which it expects the drug developer to yield similar results.<div class=\"tiny-share-widget\" data-id=\"586351\" data-linked=\"Gilead (GILD -0.9%) slips a bit today after Bristol-Myers (BMY +3.2%) and Abbott (ABT +3.7%)...\" data-tweet=\"$GILD $GILD $BMY - Gilead (GILD -0.9%) slips a bit today after Bristol-Myers (BMY +3.2%) and Abbott (ABT +3.7%) both reported favorable study results for their HCV drugs (I,II). Deutsche Bank defends the stock , saying the results of these studies show ... https://seekingalpha.com/news/586351?source=tweet\" data-url=\"https://seekingalpha.com/news/586351\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586281\" data-ts=\"1350320315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABT\" target=\"_blank\">ABT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abbott (ABT +3.4%) moves up after initial results from its &quot;Aviator&quot; Phase 2b study of its...</a></h4><p>Abbott (<a href=\"https://seekingalpha.com/symbol/ABT\" title=\"Abbott Laboratories\">ABT</a> <font color=\"green\">+3.4%</font>) moves up after initial results from its \"Aviator\" Phase 2b study of its interferon-free, investigational regimen for the treatment of hepatitis C indicated that 99% of the \"treatment naive\" HCV patients - those who had never been previously treated for the virus - showed a sustained virological response. Additionally, 93% of patients in the study who had previously been unsuccessfully treated for HCV also showed sustained virological response.</p><div class=\"tiny-share-widget\" data-id=\"586281\" data-linked=\"Abbott (ABT +3.4%) moves up after initial results from its &quot;Aviator&quot; Phase 2b study of its...\" data-tweet=\"$ABT - Abbott (ABT +3.4%) moves up after initial results from its &quot;Aviator&quot; Phase 2b study of its interferon-free, investigational regimen for the treatment of hepatitis C indicated that 99% of the &quot;treatment naive&quot; HCV patients - those who had never be... https://seekingalpha.com/news/586281?source=tweet\" data-url=\"https://seekingalpha.com/news/586281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586251\" data-ts=\"1350319515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYCC\" target=\"_blank\">CYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586251\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: CYCC +40%. BCOM +35%. IGLD +24%. YONG +16%. EQS +15%. DYAX +14%. ALN...</a></h4><b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a> <font color=\"green\">+40%</font>. <a href=\"https://seekingalpha.com/symbol/BCOM\" title=\"B Communications Ltd.\">BCOM</a> <font color=\"green\">+35%</font>. <a href=\"https://seekingalpha.com/symbol/IGLD\" title=\"Internet Gold Golden Lines Ltd.\">IGLD</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/YONG\" title=\"Yongye International Inc\">YONG</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/EQS\" title=\"Equus Total Return\">EQS</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/DYAX\" title=\"Dyax Corp.\">DYAX</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/ALN\" title=\"American Lorain Corporation\">ALN</a> <font color=\"green\">+13%</font>. BSDM <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/CLWR\" title=\"\">CLWR</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/ESYS\" title=\"Elecsys Corporation\">ESYS</a> <font color=\"green\">+9%</font>.  <br> <b>Top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/DCTH\" title=\"Delcath Systems, Inc.\">OTC:DCTH</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/PRWT\" title=\"Premier West Bancorp\">PRWT</a> <font color=\"red\">-17%</font>. DHRM <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/AMED\" title=\"AMEDISYS Inc\">AMED</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/PLXT\" title=\"PLX Technology, Inc.\">PLXT</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/GROW\" title=\"U.S. Global Investors, Inc.\">GROW</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/IMOS\" title=\"ChipMOS TECH Shs Sponsored American Depositary Receipt Repr 20 Shs\">IMOS</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/HAUP\" title=\"Hauppauge Digital, Inc.\">OTC:HAUP</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/ILMN\" title=\"Illumina, Inc.\">ILMN</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/DAC\" title=\"Danaos Corporation\">DAC</a> <font color=\"red\">-7%</font>.<div class=\"tiny-share-widget\" data-id=\"586251\" data-linked=\"Midday top 10 gainers: CYCC +40%. BCOM +35%. IGLD +24%. YONG +16%. EQS +15%. DYAX +14%. ALN...\" data-tweet=\"$CYCC $CYCC $BCOM - Midday top 10 gainers: CYCC +40%. BCOM +35%. IGLD +24%. YONG +16%. EQS +15%. DYAX +14%. ALN +13%. BSDM +11%. CLWR +11%. ESYS +9%. Top 10 Losers: OTC:DCTH -19%. PRWT -17%. DHRM -10%. AMED -9%. PLXT -9%. GROW -8%. IMOS -8%. OTC:HAUP -7... https://seekingalpha.com/news/586251?source=tweet\" data-url=\"https://seekingalpha.com/news/586251\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586211\" data-ts=\"1350317922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTNR\" target=\"_blank\">PTNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586211\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Israeli carrier Partner Communications (PTNR +4.7%) rallies on news holding firm Scailex is in...</a></h4><p>Israeli carrier Partner Communications (<a href=\"https://seekingalpha.com/symbol/PTNR\" title=\"Partner Communications Company Ltd.\">PTNR</a> <font color=\"green\">+4.7%</font>) rallies on news holding firm Scailex is <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/10/14/partnercomm-saban-idUSL5E8LE0L620121014?feedType=RSS&amp;feedName=technologySector&amp;rpc=43\">in talks</a> with media magnate Haim Saban about selling its stake in Partner: one report claims Saban will acquire a 35%-40% stake for $400M-$450M through a multi-stage deal. Rival Cellcom (<a href=\"https://seekingalpha.com/symbol/CEL\" title=\"Cellcom Israel, Ltd.\">CEL</a> <font color=\"green\">+5.3%</font>) is also higher. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=ptnr%20scailex\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"586211\" data-linked=\"Israeli carrier Partner Communications (PTNR +4.7%) rallies on news holding firm Scailex is in...\" data-tweet=\"$PTNR $PTNR $CEL - Israeli carrier Partner Communications (PTNR +4.7%) rallies on news holding firm Scailex is in talks with media magnate Haim Saban about selling its stake in Partner: one report claims Saban will acquire a 35%-40% stake for $400M-$450... https://seekingalpha.com/news/586211?source=tweet\" data-url=\"https://seekingalpha.com/news/586211\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586201\" data-ts=\"1350317708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYCC\" target=\"_blank\">CYCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cyclacel Pharmaceuticals (CYCC +40.4%) soars after saying that Phase II studies of it&#39;s lead...</a></h4><p>Cyclacel Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CYCC\" title=\"Cyclacel Pharmaceuticals, Inc.\">CYCC</a> <font color=\"green\">+40.4%</font>) soars after saying that Phase II studies of it's lead drug candidate Sapacitabine, a treatment for older patients with intermediate-2 or high-risk myelodysplastic syndrome, nearly doubled expected survival rates for elderly patients.</p><div class=\"tiny-share-widget\" data-id=\"586201\" data-linked=\"Cyclacel Pharmaceuticals (CYCC +40.4%) soars after saying that Phase II studies of it&#39;s lead...\" data-tweet=\"$CYCC - Cyclacel Pharmaceuticals (CYCC +40.4%) soars after saying that Phase II studies of it&#39;s lead drug candidate Sapacitabine, a treatment for older patients with intermediate-2 or high-risk myelodysplastic syndrome, nearly doubled expected survival ... https://seekingalpha.com/news/586201?source=tweet\" data-url=\"https://seekingalpha.com/news/586201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586151\" data-ts=\"1350317134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586151\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero (VLO -1.6%) extends last week&#39;s ~10% decline as it begins shutting several units for...</a></h4>Valero (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color=\"red\">-1.6%</font>) extends last week's ~10% decline as it <a target=\"_blank\" target=\"_blank\" href=\"http://www.reuters.com/article/2012/10/14/us-refinery-operations-valero-mckee-idUSBRE89D0IU20121014\">begins shutting several units</a> for planned maintenance, including a gasoline-making fluid catalytic cracking unit at its 156K bbl/day McKee refinery in Sunray, Tex.<div class=\"tiny-share-widget\" data-id=\"586151\" data-linked=\"Valero (VLO -1.6%) extends last week&#39;s ~10% decline as it begins shutting several units for...\" data-tweet=\"$VLO - Valero (VLO -1.6%) extends last week&#39;s ~10% decline as it begins shutting several units for planned maintenance, including a gasoline-making fluid catalytic cracking unit at its 156K bbl/day McKee refinery in Sunray, Tex. https://seekingalpha.com/news/586151?source=tweet\" data-url=\"https://seekingalpha.com/news/586151\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586141\" data-ts=\"1350317112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586141\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers (BMY +4.1%) jumps after late-breaking abstracts for The American Association for...</a></h4><p>Bristol-Myers (<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a> <font color=\"green\">+4.1%</font>) jumps after <a target=\"_blank\" href=\"http://aasld2012.abstractcentral.com/s1agxt/com.scholarone.s1agxt.s1agxt/S1A.html?&amp;CONFIG_ID=2518&amp;USER_ID=1593989&amp;ROLE_ID=16365&amp;ROLE_TYPE_ID=17&amp;PERSON2ROLE_ID=17804403&amp;WORKFLOW_ID=17&amp;CURRENT_PAGE=BROWSE_THE_PROGRAM&amp;ALLOW_EDIT_INSTRUCTIONS_FL=N&amp;SESSION_ADMIN_PERMISSION_FL=N&amp;REVIEWER_ADMIN_PERMISSION_FL=N&amp;DIRECT_LOGIN_FL=Y&amp;HASH_KEY=1JZ7qs6MYkCNBX7fFkPsXC0iNco&amp;STUB_ROLE_ID=0&amp;TIME=1350316724175&amp;SOURCE_URL=http://aasld2012.abstractcentral.com\">late-breaking abstracts</a> for The American Association for the Study of Liver Diseases annual meeting - of which <a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a> has a number of presentations on its Hep C virus studies - were posted to the organization's website this morning.</p><div class=\"tiny-share-widget\" data-id=\"586141\" data-linked=\"Bristol-Myers (BMY +4.1%) jumps after late-breaking abstracts for The American Association for...\" data-tweet=\"$BMY - Bristol-Myers (BMY +4.1%) jumps after late-breaking abstracts for The American Association for the Study of Liver Diseases annual meeting - of which BMY has a number of presentations on its Hep C virus studies - were posted to the organization&#39;s ... https://seekingalpha.com/news/586141?source=tweet\" data-url=\"https://seekingalpha.com/news/586141\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586121\" data-ts=\"1350316563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMC\" target=\"_blank\">BMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586121\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMC Software (BMC -2.5%) falls on a downgrade to Underperform from Raymond James, whose checks...</a></h4>BMC Software (<a href='https://seekingalpha.com/symbol/BMC' title='BMC Software, Inc.'>BMC</a> <font color='red'>-2.5%</font>) falls on a <a target=\"_blank\" href=\"http://www.theflyonthewall.com/permalinks/entry.php/BMCid1718921/BMC-BMC-Software-downgraded-to-Market-Perform-from-Outperform-at-Raymond-James\">downgrade to Underperform</a> from Raymond James, whose checks indicate the systems management software vendor is facing operational and sales headwinds. BMC, which reports after the close on Oct. 31, has been struggling with <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/120652\">sales issues</a> for the non-mainframe portion of its business for some time.<div class=\"tiny-share-widget\" data-id=\"586121\" data-linked=\"BMC Software (BMC -2.5%) falls on a downgrade to Underperform from Raymond James, whose checks...\" data-tweet=\"$BMC - BMC Software (BMC -2.5%) falls on a downgrade to Underperform from Raymond James, whose checks indicate the systems management software vendor is facing operational and sales headwinds. BMC, which reports after the close on Oct. 31, has been stru... https://seekingalpha.com/news/586121?source=tweet\" data-url=\"https://seekingalpha.com/news/586121\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586091\" data-ts=\"1350315843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChipMOS (IMOS -7.8%) plunges after reporting Q3 revenue of $175.5M (+6.4% Y/Y), and stating it...</a></h4><p>ChipMOS (<a href=\"https://seekingalpha.com/symbol/IMOS\" title=\"ChipMOS TECH Shs Sponsored American Depositary Receipt Repr 20 Shs\">IMOS</a> <font color=\"red\">-7.8%</font>) plunges after reporting Q3 revenue of $175.5M (+6.4% Y/Y), and stating it expects Q4 revenue to be flat to -5% Q/Q. The chip packaging/testing services firm's Q4 revenue consensus stands at $179.4M. Soft DRAM packaging sales are said to be offsetting strong LCD driver and flash memory testing sales. The report could have negative implications for DRAM makers such as Micron (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"red\">-0.1%</font>). (PR)</p><div class=\"tiny-share-widget\" data-id=\"586091\" data-linked=\"ChipMOS (IMOS -7.8%) plunges after reporting Q3 revenue of $175.5M (+6.4% Y/Y), and stating it...\" data-tweet=\"$MU $IMOS $MU - ChipMOS (IMOS -7.8%) plunges after reporting Q3 revenue of $175.5M (+6.4% Y/Y), and stating it expects Q4 revenue to be flat to -5% Q/Q. The chip packaging/testing services firm&#39;s Q4 revenue consensus stands at $179.4M. Soft DRAM packagi... https://seekingalpha.com/news/586091?source=tweet\" data-url=\"https://seekingalpha.com/news/586091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586061\" data-ts=\"1350315415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAS\" target=\"_blank\">BAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586061\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Basic Energy Services (BAS -3.6%) says it received a subpoena from the SEC and believes it is...</a></h4><p>Basic Energy Services (<a href=\"https://seekingalpha.com/symbol/BAS\" title=\"Basic Energy Services, Inc.\">BAS</a> <font color=\"red\">-3.6%</font>) says it <a target=\"_blank\" href=\"http://www.sec.gov/Archives/edgar/data/1109189/000119312512422695/d424873d8k.htm\">received a subpoena from the SEC</a> and believes it is being investigated for potential violations of securities laws in connection with a July press release discussing June 2011 operating data.</p><div class=\"tiny-share-widget\" data-id=\"586061\" data-linked=\"Basic Energy Services (BAS -3.6%) says it received a subpoena from the SEC and believes it is...\" data-tweet=\"$BAS - Basic Energy Services (BAS -3.6%) says it received a subpoena from the SEC and believes it is being investigated for potential violations of securities laws in connection with a July press release discussing June 2011 operating data. https://seekingalpha.com/news/586061?source=tweet\" data-url=\"https://seekingalpha.com/news/586061\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586041\" data-ts=\"1350314523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVLN\" target=\"_blank\">NVLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegerion Pharmaceuticals (AEGR +8.8%) trades up in reaction to a positive FDA staff report on...</a></h4><p>Aegerion Pharmaceuticals  (AEGR <font color=\"green\">+8.8%</font>) trades up in reaction to a <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-10-15/aegerion-shares-rise-on-fda-report-of-high-cholesterol-treatment.html\">positive FDA staff report</a> on its drug lomitapide. The drug treats a rare genetic disorder that causes very high cholesterol, and the report said that AEGR's plan to manage risk associated with it supports approval in adults with the most life-threatening forms. The drug is due to be reviewed on Wednesday by a committee of non-FDA medical experts, and the FDA will make a final decision by the end of December.</p><div class=\"tiny-share-widget\" data-id=\"586041\" data-linked=\"Aegerion Pharmaceuticals (AEGR +8.8%) trades up in reaction to a positive FDA staff report on...\" data-tweet=\"$NVLN $NVLNF - Aegerion Pharmaceuticals (AEGR +8.8%) trades up in reaction to a positive FDA staff report on its drug lomitapide. The drug treats a rare genetic disorder that causes very high cholesterol, and the report said that AEGR&#39;s plan to manage r... https://seekingalpha.com/news/586041?source=tweet\" data-url=\"https://seekingalpha.com/news/586041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586031\" data-ts=\"1350314483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586031\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora (P -2.7%) falls as details arrive about the long-rumored Xbox Music (NASDAQ:MSFT) a day...</a></h4>Pandora (<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color='red'>-2.7%</font>) falls as <a target=\"_blank\" href=\"http://www.bloomberg.com/news/2012-10-15/microsoft-to-begin-rolling-out-xbox-music-service.html\">details arrive</a> about the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/392101\">long-rumored</a> Xbox Music (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) a day ahead of its launch. The service bears a strong resemblance to Spotify: an ad-supported version that works on PCs and tablets will be free (it'll be Windows 8's default music service), while an ad-free version that supports the Xbox and smartphones will go for $10/month. However, iOS and Android apps won't arrive until next year. Pandora's Internet radio share thus far <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/187591\">hasn't been hurt badly</a> by growing competition. (<a target=\"_blank\" href=\"http://techcrunch.com/2012/10/14/microsoft-xbox-music/\">more</a>)<div class=\"tiny-share-widget\" data-id=\"586031\" data-linked=\"Pandora (P -2.7%) falls as details arrive about the long-rumored Xbox Music (NASDAQ:MSFT) a day...\" data-tweet=\"$P $P $MSFT - Pandora (P -2.7%) falls as details arrive about the long-rumored Xbox Music (NASDAQ:MSFT) a day ahead of its launch. The service bears a strong resemblance to Spotify: an ad-supported version that works on PCs and tablets will be free (it&#39;... https://seekingalpha.com/news/586031?source=tweet\" data-url=\"https://seekingalpha.com/news/586031\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585971\" data-ts=\"1350313953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585971\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talks break down between South Africa&#39;s top three gold producers and striking miners, failing to...</a></h4><a target=\"_blank\" href=\"http://www.foxbusiness.com/news/2012/10/15/talks-break-down-between-south-africa-gold-mines-unions/\">Talks break down</a> between South Africa's top three gold producers and striking miners, failing to reach agreement on pay proposals. <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/581591\">Strikes</a> have shut all seven of AngloGold's (<a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a> <font color=\"red\">-1.7%</font>) South African mines, which account for about a third of its total production; two of Gold Fields' (<a href=\"https://seekingalpha.com/symbol/GFI\" title=\"Gold Fields Limited\">GFI</a> <font color=\"red\">-1%</font>) mines and one operated by Harmony (<a href=\"https://seekingalpha.com/symbol/HMY\" title=\"Harmony Gold Mining Company Limited\">HMY</a> <font color=\"red\">-0.5%</font>) also are closed.<div class=\"tiny-share-widget\" data-id=\"585971\" data-linked=\"Talks break down between South Africa&#39;s top three gold producers and striking miners, failing to...\" data-tweet=\"$AU $AU $GFI - Talks break down between South Africa&#39;s top three gold producers and striking miners, failing to reach agreement on pay proposals. Strikes have shut all seven of AngloGold&#39;s (AU -1.7%) South African mines, which account for about a third ... https://seekingalpha.com/news/585971?source=tweet\" data-url=\"https://seekingalpha.com/news/585971\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"586001\" data-ts=\"1350313466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/586001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday (WDAY +6.9%) rallies above $52, adding to Friday&#39;s huge post-IPO jump. While the...</a></h4><p>Workday (<a href=\"https://seekingalpha.com/symbol/WDAY\" title=\"Workday\">WDAY</a> <font color=\"green\">+6.9%</font>) rallies above $52, adding to Friday's huge <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/583751\">post-IPO jump</a>. While the company's sky-high valuation <a target=\"_blank\" href=\"https://seekingalpha.com/article/921931-workday-with-shares-trading-up-116-above-the-midpoint-price-a-next-bubble-is-in-the-making\">fuels debate</a> over whether a bubble has formed in high-growth enterprise/cloud software names, Workday execs have been <a target=\"_blank\" href=\"http://allthingsd.com/20121012/workday-takes-off-like-a-rocket-and-ceos-like-their-model/\">touting the potential</a> of its HR and ERP software to disrupt a global market of 23K+ enterprises with 1K or more employees - Workday's solutions are currently used by less than 400 of them. The company also says it's interested in expanding into analytics. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=workday\">more</a>)</p><div class=\"tiny-share-widget\" data-id=\"586001\" data-linked=\"Workday (WDAY +6.9%) rallies above $52, adding to Friday&#39;s huge post-IPO jump. While the...\" data-tweet=\"$WDAY - Workday (WDAY +6.9%) rallies above $52, adding to Friday&#39;s huge post-IPO jump. While the company&#39;s sky-high valuation fuels debate over whether a bubble has formed in high-growth enterprise/cloud software names, Workday execs have been touting t... https://seekingalpha.com/news/586001?source=tweet\" data-url=\"https://seekingalpha.com/news/586001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585961\" data-ts=\"1350312735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585961\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink Swann ups Eli Lilly (LLY +5.3%) to Outperform and raises sales estimates on the back of...</a></h4><p>Leerink Swann ups Eli Lilly (<a href=\"https://seekingalpha.com/symbol/LLY\" title=\"Eli Lilly and Company\">LLY</a> <font color=\"green\">+5.3%</font>) to Outperform and <a target=\"_blank\" href=\"http://www.benzinga.com/news/11/08/1820940/leerink-swann-upgrades-eli-lilly-to-market-perform\">raises sales estimates</a> on the back of positive <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/585581\">trial results</a> for its gastric cancer treatment, ramucirumab. The firm thinks the recently released data shows encouraging potential for use on other tumor types, which could boost sales and lower the drug's overall marketing risk outlook.</p><div class=\"tiny-share-widget\" data-id=\"585961\" data-linked=\"Leerink Swann ups Eli Lilly (LLY +5.3%) to Outperform and raises sales estimates on the back of...\" data-tweet=\"$LLY - Leerink Swann ups Eli Lilly (LLY +5.3%) to Outperform and raises sales estimates on the back of positive trial results for its gastric cancer treatment, ramucirumab. The firm thinks the recently released data shows encouraging potential for use o... https://seekingalpha.com/news/585961?source=tweet\" data-url=\"https://seekingalpha.com/news/585961\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585951\" data-ts=\"1350312341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIO\" target=\"_blank\">FIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fusion-io (FIO -3.6%) slides after Jim Cramer advises against buying shares on M&amp;amp;A hopes....</a></h4>Fusion-io (<a href='https://seekingalpha.com/symbol/FIO' title='Fusion-io, Inc.'>FIO</a> <font color='red'>-3.6%</font>) slides after <a target=\"_blank\" href=\"http://www.thestreet.com/story/11736125/1/mad-money-lightning-round-lilly-is-still-a-buy.html\">Jim Cramer</a> advises against buying shares on <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/494281\">M&amp;A hopes</a>. The maker of high-end server flash memory subsystems reports after the close on Oct. 24.<div class=\"tiny-share-widget\" data-id=\"585951\" data-linked=\"Fusion-io (FIO -3.6%) slides after Jim Cramer advises against buying shares on M&amp;amp;A hopes....\" data-tweet=\"$FIO - Fusion-io (FIO -3.6%) slides after Jim Cramer advises against buying shares on M&amp;A hopes. The maker of high-end server flash memory subsystems reports after the close on Oct. 24. https://seekingalpha.com/news/585951?source=tweet\" data-url=\"https://seekingalpha.com/news/585951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585891\" data-ts=\"1350310800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HZNP\" target=\"_blank\">HZNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Horizon Pharma (HZNP +1.5%) ticks up after announcing that its SkyePharma unit has received a...</a></h4><p>Horizon Pharma (<a href=\"https://seekingalpha.com/symbol/HZNP\" title=\"Horizon Pharma plc\">HZNP</a> <font color=\"green\">+1.5%</font>) ticks up after announcing that its SkyePharma unit has received a Notice of Allowance from the USPTO for its application \"Delayed Release Tablet with Defined Core Geometry\" which covers Rayos, its previously approved pain reliever for patients with rheumatoid arthritis.</p><div class=\"tiny-share-widget\" data-id=\"585891\" data-linked=\"Horizon Pharma (HZNP +1.5%) ticks up after announcing that its SkyePharma unit has received a...\" data-tweet=\"$HZNP - Horizon Pharma (HZNP +1.5%) ticks up after announcing that its SkyePharma unit has received a Notice of Allowance from the USPTO for its application &quot;Delayed Release Tablet with Defined Core Geometry&quot; which covers Rayos, its previously approved ... https://seekingalpha.com/news/585891?source=tweet\" data-url=\"https://seekingalpha.com/news/585891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585881\" data-ts=\"1350310735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585881\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;amp;T (T -1.1%) and Verizon (VZ -1.1%) edge lower after Sprint (S +0.2%) and SoftBank...</a></h4><p>AT&amp;T (<a href=\"https://seekingalpha.com/symbol/T\" title=\"AT&amp;T Inc.\">T</a> <font color=\"red\">-1.1%</font>) and Verizon (<a href=\"https://seekingalpha.com/symbol/VZ\" title=\"Verizon Communications\">VZ</a> <font color=\"red\">-1.1%</font>) edge lower after Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+0.2%</font>) and SoftBank (<a href=\"https://seekingalpha.com/symbol/SFTBF\" title=\"SoftBank Group\">OTCPK:SFTBF</a>) make their deal official - shares had already <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/581371\">fallen a bit</a> on Thursday following initial reports about the deal. In the PR announcing the acquisition, SoftBank CEO Masayoshi Son bragged about <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/584771\">his company's success</a> in taking Japanese mobile share by \"by introducing differentiated products to an incumbent-led market.\" SoftBank <font color=\"red\">fell 4.9%</font> in Tokyo today, adding to Friday's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/582891\">big losses.</a> (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=sprint%20softbank\">more</a>)</p><div class=\"tiny-share-widget\" data-id=\"585881\" data-linked=\"AT&amp;amp;T (T -1.1%) and Verizon (VZ -1.1%) edge lower after Sprint (S +0.2%) and SoftBank...\" data-tweet=\"$T $T $VZ - AT&amp;T (T -1.1%) and Verizon (VZ -1.1%) edge lower after Sprint (S +0.2%) and SoftBank (OTCPK:SFTBF) make their deal official - shares had already fallen a bit on Thursday following initial reports about the deal. In the PR announcing the acq... https://seekingalpha.com/news/585881?source=tweet\" data-url=\"https://seekingalpha.com/news/585881\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585871\" data-ts=\"1350310212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASRT\" target=\"_blank\">ASRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Depomed (DEPO +3.5%) pops after saying its New Drug Application for Serada was accepted for...</a></h4><p>Depomed (DEPO <font color=\"green\">+3.5%</font>) pops after saying its New Drug Application for Serada was accepted for filing by the FDA. In addition, the FDA has informed the company that the it's Reproductive Health Drugs Advisory Committee will also discuss the drug at an Advisory Committee meeting tentatively scheduled for March 4, 2013.</p><div class=\"tiny-share-widget\" data-id=\"585871\" data-linked=\"Depomed (DEPO +3.5%) pops after saying its New Drug Application for Serada was accepted for...\" data-tweet=\"$ASRT - Depomed (DEPO +3.5%) pops after saying its New Drug Application for Serada was accepted for filing by the FDA. In addition, the FDA has informed the company that the it&#39;s Reproductive Health Drugs Advisory Committee will also discuss the drug at... https://seekingalpha.com/news/585871?source=tweet\" data-url=\"https://seekingalpha.com/news/585871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585841\" data-ts=\"1350309736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MM\" target=\"_blank\">MM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Millennial Media (MM -5.6%) dives after: 1) Pre-announcing Q3 revenue will be in a range of...</a></h4><p>Millennial Media (<a href=\"https://seekingalpha.com/symbol/MM\" title=\"Millennial Media, Inc.\">MM</a> <font color=\"red\">-5.6%</font>) dives after: 1) Pre-announcing Q3 revenue will be in a range of $46.5M-$47M (above a $44.6M consensus), and net loss will amount to $1.9M-$2.5M. 2) Announcing a 10M-share stock offering. 1M shares will be new, and 9M will be sold by insiders. Millennial's lockup expiration <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/555871\">recently ended</a>.</p><div class=\"tiny-share-widget\" data-id=\"585841\" data-linked=\"Millennial Media (MM -5.6%) dives after: 1) Pre-announcing Q3 revenue will be in a range of...\" data-tweet=\"$MM - Millennial Media (MM -5.6%) dives after: 1) Pre-announcing Q3 revenue will be in a range of $46.5M-$47M (above a $44.6M consensus), and net loss will amount to $1.9M-$2.5M. 2) Announcing a 10M-share stock offering. 1M shares will be new, and 9M wi... https://seekingalpha.com/news/585841?source=tweet\" data-url=\"https://seekingalpha.com/news/585841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585831\" data-ts=\"1350309690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aug Business Inventories: +0.6% to $1,601.7B vs. +0.5% expected and +0.8% prior. Sales +0.5% to...</a></h4><b><a target=\"_blank\" href=\"http://www.census.gov/mtis/\">Aug Business Inventories:</a></b> <b>+0.6% to $1,601.7B</b> vs. +0.5% expected and +0.8% prior. Sales +0.5% to $1,246.6B. Inventory/sales ratio was 1.28.<div class=\"tiny-share-widget\" data-id=\"585831\" data-linked=\"Aug Business Inventories: +0.6% to $1,601.7B vs. +0.5% expected and +0.8% prior. Sales +0.5% to...\" data-tweet=\"Aug Business Inventories: +0.6% to $1,601.7B vs. +0.5% expected and +0.8% prior. Sales +0.5% to $1,246.6B. Inventory/sales ratio was 1.28. https://seekingalpha.com/news/585831?source=tweet\" data-url=\"https://seekingalpha.com/news/585831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585811\" data-ts=\"1350309588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585811\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delcath (OTC:DCTH) plummets 15.3% after saying that the FDA has accepted its Chemosat delivery...</a></h4><p>Delcath (<a href=\"https://seekingalpha.com/symbol/DCTH\" title=\"Delcath Systems, Inc.\">OTC:DCTH</a>) <font color=\"red\">plummets 15.3%</font> after saying that the FDA has accepted its Chemosat delivery system to treat a form of liver cancer <a target=\"_blank\" href=\"http://www.businessweek.com/ap/2012-10-15/fda-accepts-delcath-cancer-treatment-for-review\">for a standard review</a> and not a priority one, as the company requested. That means that the agency has up to ten months to decide whether to approve the Chemosat system rather than six, as per a priority assessment. (PR)</p><div class=\"tiny-share-widget\" data-id=\"585811\" data-linked=\"Delcath (OTC:DCTH) plummets 15.3% after saying that the FDA has accepted its Chemosat delivery...\" data-tweet=\"$DCTH - Delcath (OTC:DCTH) plummets 15.3% after saying that the FDA has accepted its Chemosat delivery system to treat a form of liver cancer for a standard review and not a priority one, as the company requested. That means that the agency has up to te... https://seekingalpha.com/news/585811?source=tweet\" data-url=\"https://seekingalpha.com/news/585811\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585761\" data-ts=\"1350308327\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phase IIb data that Sarepta Therapeutics (SRPT +2.9% to $27.88) presented over the weekend shows...</a></h4><p>Phase IIb data that Sarepta Therapeutics (<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"green\">+2.9%</font> to $27.88) <a target=\"_blank\" href=\"http://finance.yahoo.com/news/sarepta-dmd-drug-clearly-active-123137587.html\">presented over the weekend</a> shows that its eteplirsen treatment for Duchenne Muscular Dystrophy is effective. Piper Jaffray says the drug has the potential for accelerated approval and reiterates its Overweight rating on Sarepta with a $38 price target.</p><div class=\"tiny-share-widget\" data-id=\"585761\" data-linked=\"Phase IIb data that Sarepta Therapeutics (SRPT +2.9% to $27.88) presented over the weekend shows...\" data-tweet=\"$SRPT - Phase IIb data that Sarepta Therapeutics (SRPT +2.9% to $27.88) presented over the weekend shows that its eteplirsen treatment for Duchenne Muscular Dystrophy is effective. Piper Jaffray says the drug has the potential for accelerated approval a... https://seekingalpha.com/news/585761?source=tweet\" data-url=\"https://seekingalpha.com/news/585761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585751\" data-ts=\"1350308021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Some details about SoftBank/Sprint: 55% of existing Sprint (S +0.5%) shares will be purchased at...</a></h4><a target=\"_blank\" href=\"http://www.zdnet.com/softbank-as-sprints-savior-what-20-1-billion-does-doesnt-do-7000005765/\">Some details</a> about <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585231\">SoftBank/Sprint</a>: 55% of existing Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+0.5%</font>) shares will be purchased at $7.30/share for $12.1B. Another $8B will be spent to obtain Sprint shares (via new stock and a convertible bond) at $5.25 apiece. SoftBank will also get a warrant to buy 55M shares at $5.25. The deal is expected to close in mid-2013. Though Sprint <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585321\">isn't required</a> to take any action regarding Clearwire (<a href=\"https://seekingalpha.com/symbol/CLWR\" title=\"\">CLWR</a> <font color=\"green\">+20.3%</font>), that $8B could facilitate a future deal, while allowing Sprint to pay down part of its $21B debt load. Dan Hesse will remain Sprint's CEO.<div class=\"tiny-share-widget\" data-id=\"585751\" data-linked=\"Some details about SoftBank/Sprint: 55% of existing Sprint (S +0.5%) shares will be purchased at...\" data-tweet=\"$S $SFTBF - Some details about SoftBank/Sprint: 55% of existing Sprint (S +0.5%) shares will be purchased at $7.30/share for $12.1B. Another $8B will be spent to obtain Sprint shares (via new stock and a convertible bond) at $5.25 apiece. SoftBank will ... https://seekingalpha.com/news/585751?source=tweet\" data-url=\"https://seekingalpha.com/news/585751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585731\" data-ts=\"1350307770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YONG\" target=\"_blank\">YONG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585731\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crop-nutrients maker Yongye International (NASDAQ:YONG) up 18.4% premarket on CEO Zishen Wu&#39;s...</a></h4><p>Crop-nutrients maker Yongye International (NASDAQ:<a href=\"https://seekingalpha.com/symbol/YONG\" title=\"Yongye International Inc\">YONG</a>) <font color=\"green\">up 18.4%</font> premarket on CEO Zishen Wu's plans to <a target=\"_blank\" href=\"http://www.reuters.com/article/2012/10/15/yongyeinternational-offer-idUSL3E8LF7PU20121015\">take the company private</a> at $6.60/share - a 38% premium to Friday's close that values the company at $334M.</p><div class=\"tiny-share-widget\" data-id=\"585731\" data-linked=\"Crop-nutrients maker Yongye International (NASDAQ:YONG) up 18.4% premarket on CEO Zishen Wu&#39;s...\" data-tweet=\"$YONG - Crop-nutrients maker Yongye International (NASDAQ:YONG) up 18.4% premarket on CEO Zishen Wu&#39;s plans to take the company private at $6.60/share - a 38% premium to Friday&#39;s close that values the company at $334M. https://seekingalpha.com/news/585731?source=tweet\" data-url=\"https://seekingalpha.com/news/585731\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585681\" data-ts=\"1350306946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EDU\" target=\"_blank\">EDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Oriental Education (NYSE:EDU) fires off a 14.5% premarket gain after Oppenheimer takes its...</a></h4><p>New Oriental Education (NYSE:<a href=\"https://seekingalpha.com/symbol/EDU\" title=\"New Oriental Education &amp; Technology Group Inc.\">EDU</a>) fires off a <font color=\"green\">14.5% premarket gain</font> after Oppenheimer <a target=\"_blank\" href=\"https://twitter.com/Briefingcom/status/257810326777626624\">takes</a> its rating on the name up to Outperform. Shares have now recovered more than half the ground lost since a SEC investigation and an attack from Muddy Waters drove them to single digits earlier in the year.</p><div class=\"tiny-share-widget\" data-id=\"585681\" data-linked=\"New Oriental Education (NYSE:EDU) fires off a 14.5% premarket gain after Oppenheimer takes its...\" data-tweet=\"$EDU - New Oriental Education (NYSE:EDU) fires off a 14.5% premarket gain after Oppenheimer takes its rating on the name up to Outperform. Shares have now recovered more than half the ground lost since a SEC investigation and an attack from Muddy Waters... https://seekingalpha.com/news/585681?source=tweet\" data-url=\"https://seekingalpha.com/news/585681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585671\" data-ts=\"1350306945\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: U.S. stock futures follow EU shares nicely higher after encouraging trade and...</a></h4><b>Market preview:</b> U.S. stock futures follow EU shares nicely higher after encouraging <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585041\">trade</a> and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585181\">inflation</a> data out of China and and better-than-expected <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585531\">retail sales</a> in the U.S. The S&amp;P benchmark is <font color=\"green\">+0.6%</font>. Sprint is <font color=\"green\">+2.3%</font> following <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=sprint+softbank\">confirmation</a> that it's going Japanese, while Clearwire <font color=\"green\">surges 15.95%</font> even though it's not going to be part of the deal. <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585121\">Later</a> : Business Inventories, Fed speak<div class=\"tiny-share-widget\" data-id=\"585671\" data-linked=\"Market preview: U.S. stock futures follow EU shares nicely higher after encouraging trade and...\" data-tweet=\"Market preview: U.S. stock futures follow EU shares nicely higher after encouraging trade and inflation data out of China and and better-than-expected retail sales in the U.S. The S&amp;P benchmark is +0.6%. Sprint is +2.3% following confirmation that it&#39;s ... https://seekingalpha.com/news/585671?source=tweet\" data-url=\"https://seekingalpha.com/news/585671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585661\" data-ts=\"1350306654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YONG\" target=\"_blank\">YONG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585661\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: YONG +15%. CLWR +14%. EDU +14%. AEGR +14%. CEL +9%. MTSL +8%. CTIC +8%. ISIS...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/YONG\" title=\"Yongye International Inc\">YONG</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/CLWR\" title=\"\">CLWR</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/EDU\" title=\"New Oriental Education &amp; Technology Group Inc.\">EDU</a> <font color=\"green\">+14%</font>. AEGR <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/CEL\" title=\"Cellcom Israel, Ltd.\">CEL</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/MTSL\" title=\"MER Telemanagement Solutions Ltd.\">MTSL</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+8%</font>. ISIS <font color=\"green\">+7%</font>. <br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/DCTH\" title=\"Delcath Systems, Inc.\">OTC:DCTH</a> <font color=\"red\">-12%</font>.<div class=\"tiny-share-widget\" data-id=\"585661\" data-linked=\"Premarket gainers: YONG +15%. CLWR +14%. EDU +14%. AEGR +14%. CEL +9%. MTSL +8%. CTIC +8%. ISIS...\" data-tweet=\"$YONG $YONG $S - Premarket gainers: YONG +15%. CLWR +14%. EDU +14%. AEGR +14%. CEL +9%. MTSL +8%. CTIC +8%. ISIS +7%. Losers: OTC:DCTH -12%. https://seekingalpha.com/news/585661?source=tweet\" data-url=\"https://seekingalpha.com/news/585661\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585651\" data-ts=\"1350306642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585651\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Instruments (NYSE:TXN) +2.3% following a report it&#39;s in talks to sell its OMAP app...</a></h4><p>Texas Instruments (NYSE:<a href=\"https://seekingalpha.com/symbol/TXN\" title=\"Texas Instruments Inc.\">TXN</a>) <font color=\"green\">+2.3%</font> following a report it's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585221\">in talks to sell</a> its OMAP app processor business to Amazon. Such a deal would be a blow to Nvidia (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a>), which has been seen as a beneficiary of TI's decision to retreat from the app processor market, and was once (inaccurately) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/103227\">rumored</a> to have scored a design win for the second-gen Kindle Fire. But a TI/Amazon deal could clear the way for Nvidia's Tegra processor to be designed into future Barnes &amp; Noble Nooks.</p><div class=\"tiny-share-widget\" data-id=\"585651\" data-linked=\"Texas Instruments (NYSE:TXN) +2.3% following a report it&#39;s in talks to sell its OMAP app...\" data-tweet=\"$TXN $TXN $NVDA - Texas Instruments (NYSE:TXN) +2.3% following a report it&#39;s in talks to sell its OMAP app processor business to Amazon. Such a deal would be a blow to Nvidia (NASDAQ:NVDA), which has been seen as a beneficiary of TI&#39;s decision to retrea... https://seekingalpha.com/news/585651?source=tweet\" data-url=\"https://seekingalpha.com/news/585651\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585371\" data-ts=\"1350301768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNX\" target=\"_blank\">CNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585371\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consol Energy (NYSE:CNX) -2.7% premarket as it warns of a surprise loss in Q3, vs. expected EPS...</a></h4><p>Consol Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a>) <font color=\"red\">-2.7%</font> premarket as it <a target=\"_blank\" href=\"http://www.marketwatch.com/story/consol-sees-surprise-q3-loss-amid-mine-idlings-2012-10-15\">warns of a surprise loss in Q3</a>, vs. expected EPS of $0.35. The culprit is weak demand in thermal coal used for electricity: \"While precise figures are not yet available, it is clear that the company's previously announced planned and unplanned mine idlings took their toll,\" says CFO William Lyons.</p><div class=\"tiny-share-widget\" data-id=\"585371\" data-linked=\"Consol Energy (NYSE:CNX) -2.7% premarket as it warns of a surprise loss in Q3, vs. expected EPS...\" data-tweet=\"$CNX - Consol Energy (NYSE:CNX) -2.7% premarket as it warns of a surprise loss in Q3, vs. expected EPS of $0.35. The culprit is weak demand in thermal coal used for electricity: &quot;While precise figures are not yet available, it is clear that the company&#39;... https://seekingalpha.com/news/585371?source=tweet\" data-url=\"https://seekingalpha.com/news/585371\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585361\" data-ts=\"1350301340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Clearwire (CLWR) roar to a 9.5% gain premarket after Softbank&#39;s deal to take a...</a></h4><p>Shares of Clearwire (<a href=\"https://seekingalpha.com/symbol/CLWR\" title=\"\">CLWR</a>) roar to a <font color=\"green\">9.5% gain</font> premarket after Softbank's deal to take a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585321\">majority stake</a> in Sprint could help it open the door to take a stab at its networking partner Clearwire.</p><div class=\"tiny-share-widget\" data-id=\"585361\" data-linked=\"Shares of Clearwire (CLWR) roar to a 9.5% gain premarket after Softbank&#39;s deal to take a...\" data-tweet=\"$S - Shares of Clearwire (CLWR) roar to a 9.5% gain premarket after Softbank&#39;s deal to take a majority stake in Sprint could help it open the door to take a stab at its networking partner Clearwire. https://seekingalpha.com/news/585361?source=tweet\" data-url=\"https://seekingalpha.com/news/585361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585261\" data-ts=\"1350291337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585261\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EU shares are solidly higher mid-morning trading following positive export and inflation data...</a></h4>EU shares are <a target=\"_blank\" href=\"http://www.marketwatch.com/story/europe-stocks-rise-after-chinese-data-banks-up-2012-10-15\">solidly higher</a> mid-morning trading following positive export and inflation data out of China even though the latter's shares have fallen. Euro STOXX 50 <font color=\"green\">+0.95%</font>, London <font color=\"green\">+0.3%</font>, Paris <font color=\"green\">+1%</font>, Frankfurt <font color=\"green\">+0.8%</font>, Madrid <font color=\"green\">+0.8%</font>, Milan <font color=\"green\">+0.8%</font>.<div class=\"tiny-share-widget\" data-id=\"585261\" data-linked=\"EU shares are solidly higher mid-morning trading following positive export and inflation data...\" data-tweet=\"EU shares are solidly higher mid-morning trading following positive export and inflation data out of China even though the latter&#39;s shares have fallen. Euro STOXX 50 +0.95%, London +0.3%, Paris +1%, Frankfurt +0.8%, Madrid +0.8%, Milan +0.8%. https://seekingalpha.com/news/585261?source=tweet\" data-url=\"https://seekingalpha.com/news/585261\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585201\" data-ts=\"1350286176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585201-zte-shares-plunge-15_1-percent-in-hong-kong-after-chinas-second-largest-telecom-equipment-maker-warns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZTE shares plunge 15.1% in Hong Kong after China&#39;s second-largest telecom-equipment maker warns...</a></h4><p>ZTE shares <font color=\"red\">plunge 15.1%</font> in Hong Kong after China's second-largest telecom-equipment maker warns that it will make a <a href=\"http://www.cnbc.com/id/49412417\" target=\"_blank\">Q3 loss</a> of up to 2B yuan ($319.1M). ZTE blames a delay in some overseas deals and a large number of low-margin contracts in Europe, Asia and the domestic market. U.S.-listed shares on watch include ALU (<font color=\"red\">-1.7%</font> in Paris), <a href=\"https://seekingalpha.com/symbol/ERIC\" title=\"LM Ericsson Telephone Company\">ERIC</a> (<font color=\"red\">-0.85%</font> in Stockholm), <a href=\"https://seekingalpha.com/symbol/CSCO\" title=\"Cisco Systems, Inc.\">CSCO</a>, <a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a>,<a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a>, <a href=\"https://seekingalpha.com/symbol/MMI\" title=\"Marcus &amp; Millichap, Inc.\">MMI</a>, <a href=\"https://seekingalpha.com/symbol/BBND\" title=\"BigBand Networks, Inc.\">BBND</a>. (PR)</p><div class=\"tiny-share-widget\" data-id=\"585201\" data-linked=\"ZTE shares plunge 15.1% in Hong Kong after China&#39;s second-largest telecom-equipment maker warns...\" data-tweet=\"$ERIC $ERIC $CSCO - ZTE shares plunge 15.1% in Hong Kong after China&#39;s second-largest telecom-equipment maker warns. https://seekingalpha.com/news/585201-zte-shares-plunge-15_1-percent-in-hong-kong-after-chinas-second-largest-telecom-equipment-maker-warns?source=tweet\" data-url=\"https://seekingalpha.com/news/585201-zte-shares-plunge-15_1-percent-in-hong-kong-after-chinas-second-largest-telecom-equipment-maker-warns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"585191\" data-ts=\"1350285169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/585191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asian shares are mixed as positive Chinese data (I, II) fails to ease concerns about the...</a></h4><b><a target=\"_blank\" href=\"http://online.wsj.com/article/SB10000872396390443675404578057370574950506.html\">Asian shares</a></b> are mixed as positive Chinese data (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585181\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/585041\">II</a>) fails to ease concerns about the prospects for global growth. \"These days there seems to be a lot of attention (paid) to one bad number and not a lot of attention (paid) to one good number,\" says BT Investment's Joe Bracken. Japan <font color=\"green\">+0.5%</font>, Hong Kong flat, China <font color=\"red\">-0.5%</font>, India <font color=\"red\">-0.4%</font>.<div class=\"tiny-share-widget\" data-id=\"585191\" data-linked=\"Asian shares are mixed as positive Chinese data (I, II) fails to ease concerns about the...\" data-tweet=\"Asian shares are mixed as positive Chinese data (I, II) fails to ease concerns about the prospects for global growth. &quot;These days there seems to be a lot of attention (paid) to one bad number and not a lot of attention (paid) to one good number,&quot; says B... https://seekingalpha.com/news/585191?source=tweet\" data-url=\"https://seekingalpha.com/news/585191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 AM </div></div></li>","count":53,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}